๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Pharmacokinetics of a Test Dose of Intravenous Busulfan Guide Dose Modifications to Achieve an Optimal Area Under the Curve of a Single Daily Dose of Intravenous Busulfan in Children Undergoing a Reduced-Intensity Conditioning Regimen with Hematopoietic Stem Cell Transplantation

โœ Scribed by Morris Kletzel; David Jacobsohn; Reggie Duerst

Book ID
116278973
Publisher
Elsevier Science
Year
2006
Tongue
English
Weight
194 KB
Volume
12
Category
Article
ISSN
1083-8791

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

229: Twice-Daily Intravenous (IV) Busulf
229: Twice-Daily Intravenous (IV) Busulfan (Bu) x 4 Days in Children Undergoing a Reduced-Intensity Conditioning (RIC) Regimen with Allogeneic Hematopoietic Stem Cell Transplantation (AlloHSCT) is Safe and Well-Tolerated but Results in Significantly Increased Bu Clearance (CL) and Decreased Area Under the Curve (AUC) and Half-Life (t1/2) When Compared to IV Bu Twice-Daily Dosing Pharmacokinetics (PK) in Adults
โœ I. Waxman; M. Bhatia; M. Milone; L.M. Shaw; L. Baldinger; O. Militano; J. Garvin ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 60 KB